MNPR vs AAPL · $431.4M cap vs P/E 39, rev $416.16B
Monopar Therapeutics Inc (MNPR) versus Apple Inc (AAPL) — a side-by-side from cached financials, not a winner call.
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
Apple Inc (AAPL) is a consumer electronics company listed on US. It is led by Timothy D. Cook.
Latest reported MNPR revenue for 2026-06-30 was $0. Net income was -$9.2M. MNPR currently screens at market cap $431.4M.
Latest reported AAPL revenue for 2025-09-27 was $416.16B. Net income was $112.01B. Revenue was up 6.4% from 2024-09-28 to 2025-09-27. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.
MNPR currently screens at market cap $431.4M. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.
Not investment advice. Open the MNPR and AAPL stock pages for the full models.
Not investment advice.